Literature DB >> 647993

Influence of hyperprolactinaemia due to metoclopramide on gonadal function in men.

P Falaschi, G Frajese, F Sciarra, A Rocco, C Conti.   

Abstract

Five clinically normal male volunteers were given metoclopramide, 10 mg t.d.s. for 6 weeks. During treatment prolactin concentrations were elevated (over 50 ng/ml) in all. LH, FSH, testosterone and cortisol concentrations were not altered. No change was observed in LH or FSH responses to LHRH testing 4 weeks after the beginning of therapy, compared with pre-treatment values. A reduction in seminal volume and total sperm count were observed in each subject. Four noticed a decrease in libido and three lost spontaneous erections. While the metoclopramide-induced hyperprolactinaemia could be the cause of the observed changes in semen and erectile activity, it is possible that this dopamine receptor blocking drug might directly affect central or peripheral mechanism of erection, the testes or accessory organs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647993     DOI: 10.1111/j.1365-2265.1978.tb02178.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Metoclopramide-induced reversible impotence.

Authors:  R G Berlin
Journal:  West J Med       Date:  1986-03

2.  The pituitary stalk effect: is it a passing phenomenon?

Authors:  Marvin Bergsneider; Leili Mirsadraei; William H Yong; Noriko Salamon; Michael Linetsky; Marilene B Wang; David L McArthur; Anthony P Heaney
Journal:  J Neurooncol       Date:  2014-02-19       Impact factor: 4.130

3.  Effects of sulpiride induced hyperprolactinemia on testosterone secretion and metabolism before and after HCG in normal men.

Authors:  G P Bernini; M Gasperi; F Franchi; M Luisi
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

4.  Prolactin secreting adenoma in man and the role of prolactin in spermatogenesis.

Authors:  F Fraioli; D Paolucci; F Dondero; G Spera; A Isidori
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

5.  Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines.

Authors:  Noura H Abd Ellah; Esraa A Ahmed; Rasha B Abd-Ellatief; Marwa F Ali; Asmaa M Zahran; Helal F Hetta
Journal:  Int J Nanomedicine       Date:  2019-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.